RevistaLab
The US Life Science or Biotech real estate sector has seen tremendous growth during the past 3 years. Overall, since 2Q22, the US Life Science sector has grown by 17% to 401 million square feet (MSF) in 2Q25.
With many state-of-the-art, brand-new research facilities sitting empty across major research clusters in the U.S., established pharmaceutical and biotechnology firms have an opportunity to secure ideal spaces in prime locations. …
Last year Life Science inventory in the top 3 clusters, Boston, San Francisco & San Diego, grew by over 10%. With this incredible growth, combined with softer space demand, many …
With a significant amount of new inventory entering the market and weaker demand for space due to the volatile funding environment, the top three life science real estate markets—Boston, San …
RevistaLab.com recently held its 4th quarter life science real estate update. Revista principals, Hilda Martin and Mike Hargrave presented RevistaLab data on construction trends, transactions, occupancies, supply/demand fundamentals across the …
Boston is the center of the US Life Science universe, and it has been even more of a focal point for the investment community in the past few years. Not …